Results 191 to 200 of about 22,264 (222)
Some of the next articles are maybe not open access.
Thrombotic Thrombocytopenic Purpura: The Masquerader
Southern Medical Journal, 2009Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder with a mortality rate of up to 90% if left untreated, and is characterized by microvascular thrombi, mainly in small arteries and capillaries, thrombocytopenia, hemolysis, and neurological abnormalities.
Anil, Patel, Harsh, Patel, Anush, Patel
openaire +2 more sources
Thrombotic thrombocytopenic purpura in pregnancy
American Journal of Obstetrics and Gynecology, 1962Abstract The fourth case of thrombotic thrombocytopenic purpura complicating pregnancy has been reported, the subject briefly reviewed, and therapy discussed as to the advantages and disadvantages of medical versus surgical treatment.
J A, O'LEARY, , MARCHETTIAA
openaire +2 more sources
Fibrinogenolysis in thrombotic thrombocytopenic purpura
American Journal of Hematology, 1989AbstractCoagulo‐fibrinolytic factors were studied in five patients suffering from thrombotic thrombocytopenic purpura (TTP). The change in coagulation factors in the acute stage was mild compared with that found in disseminated intravascular coagulation (DIC).
E, Kakishita +5 more
openaire +2 more sources
Thrombotic Thrombocytopenic Purpura in Pregnancy
JAMA: The Journal of the American Medical Association, 1963THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) is being diagnosed with increasing frequency. Five cases have been reported in which the disease occurred as a complication of pregnancy.1-4We are here presenting a synopsis of these cases and are adding a sixth case together with a discussion of diagnosis and management.
W, SOLOMON +3 more
openaire +2 more sources
Thrombotic thrombocytopenic purpura
JAAPA, 2021Zachary, Lavender, Lauren, Collin
openaire +2 more sources
Management of thrombotic thrombocytopenic purpura
Transfusion Clinique et Biologique, 2017Daily therapeutic plasma exchange (TPE) transformed the historically fatal prognosis of acquired, anti-ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura (TTP), leading to the current overall survival rates of >80%. However, relapses occur in up to 40% of patients and refractory disease with fatal outcomes still occurs, typically within the
openaire +2 more sources
Thrombotic Thrombocytopenic Purpura Today
Hospital Practice, 1999Thrombotic thrombocytopenic purpura (TTP) usually responds to plasma exchange and plasma infusion. However, until recently, it was not clear how the treatment works. New understanding of the pathophysiology of TTP has clarified that issue and suggested new therapies that may eliminate plasma infusion and its risks.
openaire +2 more sources
Evaluation and Management of Thrombotic Thrombocytopenic Purpura in the Emergency Department
Journal of Emergency Medicine, 2021Brit Long, Michael Gottlieb
exaly
Thrombotic thrombocytopenic purpura
The Hematology Journal, 2004Lämmle B +4 more
openaire +3 more sources